Measuring Studies

Please see below for further details on our studies that aim to measure disease burden.

Please click text below to find out more.

[11C]PK11195 PET as a biomarker to diagnose and monitor natural history in mitochondrial disease

This is a small pilot study to see if we can use the molecule [11C]PK11195 to diagnose and study the progression of mitochondrial disease. We aim to determine whether [11C]PK11195 binding is abnormal in the brains and central nervous system of patients with mitochondrial disease.